We are live on
!
Find out more
IAM
Iridian Asset Management Portfolio holdings
AUM
$291M
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.37%
1 Year Est. Return
+49.45%
3 Year Est. Return
+82.55%
5 Year Est. Return
+101.12%
10 Year Est. Return
+450.66%
AUM
$8.75B
AUM Growth
+$309M
(+3.7%)
Cap. Flow
-$30.7M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
38.74%
Holding
143
New
13
Increased
23
Reduced
86
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$79.6M |
| 2 |
Avient
AVNT
|
+$61.9M |
| 3 |
Herc Holdings
HRI
|
+$55.7M |
| 4 |
SEE
Sealed Air
SEE
|
+$52.9M |
| 5 |
SEMG
SEMGROUP CORPORATION
SEMG
|
+$49.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSI
LSI CORPORATION
LSI
|
+$131M |
| 2 |
Leidos
LDOS
|
+$73.6M |
| 3 |
Bausch Health
BHC
|
+$57M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$53.3M |
| 5 |
IPG
Interpublic Group of Companies
IPG
|
+$44.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.29% |
| 2 | Technology | 17.26% |
| 3 | Materials | 15.42% |
| 4 | Healthcare | 13.33% |
| 5 | Industrials | 12.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPXL
76
DELISTED
Impax Laboratories, Inc.
IPXL
| $338K | ﹤0.01% |
12,790
-2,160
| -14% | -$54K |
|
|
ATRS
77
DELISTED
Antares Pharma, Inc.
ATRS
| $337K | ﹤0.01% |
96,270
-31,740
| -25% | -$141K |
|
78
Heritage Financial
HFWA
$1.23B
| $334K | ﹤0.01% |
19,720
-5,690
| -22% | -$99.4K |
|
79
Lindsay Corp
LNN
$1.15B
| $332K | ﹤0.01% |
3,765
-1,810
| -32% | -$153K |
|
|
ANAT
80
DELISTED
American National Group, Inc. Common Stock
ANAT
| $332K | ﹤0.01% |
2,935
-1,400
| -32% | -$155K |
|
81
Gibraltar Industries
ROCK
$1.37B
| $328K | ﹤0.01% |
17,370
-8,680
| -33% | -$157K |
|
|
ISBC
82
DELISTED
Investors Bancorp, Inc.
ISBC
| $328K | ﹤0.01% |
30,290
-15,115
| -33% | -$155K |
|
|
GSIG
83
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $328K | ﹤0.01% |
25,090
-11,900
| -32% | -$140K |
|
|
CQB
84
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $326K | ﹤0.01% |
26,160
| – | – |
|
85
National Bank Holdings
NBHC
$1.92B
| $320K | ﹤0.01% |
15,940
+340
| +2% | +$6.86K |
|
|
MESG
86
DELISTED
XURA INC COM (DE)
MESG
| $320K | ﹤0.01% |
9,268
-319
| -3% | -$11.5K |
|
87
First Merchants
FRME
$2.71B
| $315K | ﹤0.01% |
14,558
-6,960
| -32% | -$148K |
|
|
QLGC
88
DELISTED
QLOGIC CORP
QLGC
| $314K | ﹤0.01% |
24,600
-11,700
| -32% | -$137K |
|
|
KRA
89
DELISTED
Kraton Corporation
KRA
| $308K | ﹤0.01% |
11,800
-9,220
| -44% | -$232K |
|
|
BGC
90
DELISTED
General Cable Corporation
BGC
| $306K | ﹤0.01% |
11,940
-5,700
| -32% | -$165K |
|
|
SGNT
91
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $294K | ﹤0.01% |
12,561
-4,819
| -28% | -$105K |
|
92
Teradyne
TER
$57.3B
| $292K | ﹤0.01% |
14,691
-6,800
| -32% | -$132K |
|
|
ZEUS
93
DELISTED
Olympic Steel
ZEUS
| $292K | ﹤0.01% |
10,169
-4,870
| -32% | -$137K |
|
94
National Presto Industries
NPK
$967M
| $291K | ﹤0.01% |
3,725
-1,850
| -33% | -$145K |
|
|
ANAD
95
DELISTED
ANADIGICS INC
ANAD
| $283K | ﹤0.01% |
+166,680
| New | +$318K |
|
|
UCP
96
DELISTED
UCP, Inc.
UCP
| $282K | ﹤0.01% |
18,750
-3,390
| -15% | -$51.5K |
|
|
BRSS
97
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $280K | ﹤0.01% |
+17,740
| New | +$299K |
|
98
Dycom Industries
DY
$12.5B
| $274K | ﹤0.01% |
8,670
-4,320
| -33% | -$124K |
|
99
Aviat Networks
AVNW
$265M
| $269K | ﹤0.01% |
28,163
-1,234
| -4% | -$14.4K |
|
100
Hanover Insurance
THG
$8.09B
| $267K | ﹤0.01% |
4,350
-2,290
| -34% | -$134K |
|
Similar funds
DP
DWM
EPIME
DIGDR
LFC
ACG
ODFS
FPM
Iridian Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Iridian Asset Management held 143 positions worth $8.75B, up 3.7% from $8.44B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Iridian Asset Management's Q1 2014 filing shows 13 new, 23 increased, 86 reduced and 17 closed positions. Its largest new stake was Myriad Genetics: 2,567,926 shares worth $87.8M. The largest sale was LSI CORPORATION, an estimated $131M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 21% a quarter earlier, followed by Technology and Materials.
- Iridian Asset Management's largest Q1 2014 buy was Myriad Genetics: 2,567,926 shares worth $87.8M.
- Iridian Asset Management added most to Herc Holdings in Q1 2014, an estimated $55.7M increase.
- Iridian Asset Management's biggest Q1 2014 reduction was Leidos, cutting an estimated $73.6M.
- Iridian Asset Management fully exited LSI CORPORATION in Q1 2014, selling an estimated $131M.
- Iridian Asset Management's ten largest holdings make up 39% of its $8.75B portfolio in Q1 2014.
- Iridian Asset Management opened 13 new positions and closed 17 in Q1 2014.
- Iridian Asset Management's portfolio value rose 3.7% quarter-over-quarter to $8.75B.
Based on Iridian Asset Management's 13F filing for Q1 2014, filed 6 May 2014.